0

530163

KERALAYUR

img img img img
No Data Available

KERALA AYURVEDA LTD. Share Price Update

As of the latest trading session, KERALA AYURVEDA LTD. is trading at ₹205.8, down by ₹-0.69 or -0.33% from its previous close. The stock has moved between ₹200.15 and ₹212.95 today. Over the past year, the stock has delivered a return of -50.88%. In the last month, it has returned -11.71%.

Investment Returns

Over 1 Month -11.71% Over 3 Months -1.09% Over 6 Months -47.20% Over 1 Year -50.88%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KERALA AYURVEDA LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 264.30
  • P/E Ratio (TTM) -17.94
  • Beta 1.54
  • Book Value / share 28.05
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -7.93
info icon alternate text

KERALA AYURVEDA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 24.57
Operating Expense 38.26
Net Profit -7.93
Net Profit Margin (%) -32.27
Earnings Per Share (EPS) -6.25
EBITDA -5.79
Effective Tax Rate (%) 11.88
Particulars DEC 2025 (Values in Cr)
Revenue 22.07
Operating Expense 26.69
Net Profit -3.47
Net Profit Margin (%) -15.72
Earnings Per Share (EPS) -3.03
EBITDA -1.08
Effective Tax Rate (%) 4.93
Particulars SEP 2025 (Values in Cr)
Revenue 21.29
Operating Expense 29.41
Net Profit -5.40
Net Profit Margin (%) -25.36
Earnings Per Share (EPS) -4.58
EBITDA -2.78
Effective Tax Rate (%) 8.00
Particulars JUN 2025 (Values in Cr)
Revenue 17.57
Operating Expense 24.99
Net Profit 2.07
Net Profit Margin (%) 11.78
Earnings Per Share (EPS) 1.73
EBITDA 4.58
Effective Tax Rate (%) 19.76
Particulars MAR 2025 (Values in Cr)
Revenue 19.35
Operating Expense 34.61
Net Profit -11.86
Net Profit Margin (%) -61.29
Earnings Per Share (EPS) -10.13
EBITDA -6.61
Effective Tax Rate (%) -9.00
Particulars MAR 2026 (Values in Cr)
Revenue 85.48
Operating Expense 119.36
Net Profit -14.74
Net Profit Margin (%) -17.24
Earnings Per Share (EPS) -12.21
EBITDA -5.08
Effective Tax Rate (%) 7.58
Particulars MAR 2025 (Values in Cr)
Revenue 72.69
Operating Expense 91.35
Net Profit -13.78
Net Profit Margin (%) -18.95
Earnings Per Share (EPS) -11.53
EBITDA -7.41
Effective Tax Rate (%) -2.22
Particulars MAR 2024 (Values in Cr)
Revenue 68.04
Operating Expense 71.21
Net Profit 0.05
Net Profit Margin (%) 0.07
Earnings Per Share (EPS) -0.44
EBITDA 6.80
Effective Tax Rate (%) 129.41
Particulars MAR 2023 (Values in Cr)
Revenue 59.12
Operating Expense 59.64
Net Profit 2.89
Net Profit Margin (%) 4.88
Earnings Per Share (EPS) 3.09
EBITDA 7.45
Effective Tax Rate (%) -21.94
Particulars MAR 2022 (Values in Cr)
Revenue 51.72
Operating Expense 50.79
Net Profit 0.89
Net Profit Margin (%) 1.72
Earnings Per Share (EPS) 1.17
EBITDA 7.88
Effective Tax Rate (%) 28.45
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 5.21
EBITDA Margin -2.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.50
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 6.13
EBITDA Margin 8.17
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 12.18
EBITDA Margin 3.11
Particulars MAR 2022 (Values in Cr)
Book Value / Share 5.79
ROE % 13.28
ROCE % 9.31
Total Debt to Total Equity 15.40
EBITDA Margin 12.30
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.22
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 12.42
EBITDA Margin 1.53
Particulars MAR 2025 (Values in Cr)
Book Value / Share 20.88
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.06
EBITDA Margin -9.51
Particulars MAR 2024 (Values in Cr)
Book Value / Share 27.24
ROE % 0.14
ROCE % 4.97
Total Debt to Total Equity 2.69
EBITDA Margin 9.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.77
ROE % 2.03
ROCE % 4.85
Total Debt to Total Equity 4.84
EBITDA Margin 7.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 10.68
ROE % 5.44
ROCE % 8.40
Total Debt to Total Equity 5.97
EBITDA Margin 14.39
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.51
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 5.01
EBITDA Margin 0.88
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.38
Total Assets 128.76
Total Liabilities 128.76
Total Equity 12.89
Share Outstanding 1
Price to Book Ratio 16.82
Return on Assets (%) -10.84
Return on Capital (%) -17.7
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 22.80
Total Assets 133.18
Total Liabilities 133.18
Total Equity 21.31
Share Outstanding 1
Price to Book Ratio 9.59
Return on Assets (%) -0.42
Return on Capital (%) -0.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.19
Total Assets 114.71
Total Liabilities 114.71
Total Equity 7.88
Share Outstanding 1
Price to Book Ratio 6.06
Return on Assets (%) -0.78
Return on Capital (%) -1.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.87
Total Assets 110.31
Total Liabilities 110.31
Total Equity 7.94
Share Outstanding 1
Price to Book Ratio 7.32
Return on Assets (%) 2.14
Return on Capital (%) 3.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.55
Total Assets 114.48
Total Liabilities 114.48
Total Equity 5.20
Share Outstanding 1
Price to Book Ratio 5.40
Return on Assets (%) -4.23
Return on Capital (%) -5.91
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.36
Total Assets 118.88
Total Liabilities 118.88
Total Equity 25.12
Share Outstanding 1
Price to Book Ratio 16.82
Return on Assets (%) -11.59
Return on Capital (%) -17.39
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 16.49
Total Assets 116.22
Total Liabilities 116.22
Total Equity 32.77
Share Outstanding 1
Price to Book Ratio 9.59
Return on Assets (%) 0.04
Return on Capital (%) 0.06
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.72
Total Assets 98.70
Total Liabilities 98.70
Total Equity 14.53
Share Outstanding 1
Price to Book Ratio 6.06
Return on Assets (%) 2.92
Return on Capital (%) 3.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 91.69
Total Liabilities 91.69
Total Equity 11.27
Share Outstanding 1
Price to Book Ratio 7.32
Return on Assets (%) 0.97
Return on Capital (%) 1.22
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.07
Total Assets 96.22
Total Liabilities 96.22
Total Equity 10.04
Share Outstanding 1
Price to Book Ratio 5.40
Return on Assets (%) -5.14
Return on Capital (%) -6.51
Particulars MAR 2025 (Values in Cr)
Net Income -12.23
Cash from Operations 6.88
Cash from Investing -14.76
Cash from Financing -9.48
Net change in Cash -19.42
Free Cash Flow 20.20
Particulars MAR 2024 (Values in Cr)
Net Income 0.65
Cash from Operations 0.08
Cash from Investing -0.45
Cash from Financing 19.83
Net change in Cash 18.41
Free Cash Flow 1.17
Particulars MAR 2023 (Values in Cr)
Net Income 4.26
Cash from Operations 10.22
Cash from Investing -7.21
Cash from Financing -1.13
Net change in Cash 1.50
Free Cash Flow 16.41
Particulars MAR 2022 (Values in Cr)
Net Income 9.32
Cash from Operations -0.50
Cash from Investing -1.90
Cash from Financing -13.27
Net change in Cash -15.68
Free Cash Flow 2.34
Particulars MAR 2021 (Values in Cr)
Net Income -0.41
Cash from Operations 7.42
Cash from Investing -1.43
Cash from Financing 6.20
Net change in Cash 12.19
Free Cash Flow 8.46
Particulars MAR 2025 (Values in Cr)
Net Income -13.48
Cash from Operations 2.23
Cash from Investing -6.47
Cash from Financing -11.93
Net change in Cash -16.13
Free Cash Flow 9.04
Particulars MAR 2024 (Values in Cr)
Net Income -0.16
Cash from Operations -4.79
Cash from Investing -0.53
Cash from Financing 20.58
Net change in Cash 14.75
Free Cash Flow -4.09
Particulars MAR 2023 (Values in Cr)
Net Income 6.81
Cash from Operations 9.11
Cash from Investing -5.32
Cash from Financing -2.27
Net change in Cash 1.52
Free Cash Flow 10.05
Particulars MAR 2022 (Values in Cr)
Net Income 7.12
Cash from Operations 8.75
Cash from Investing 0.82
Cash from Financing -10.51
Net change in Cash -0.94
Free Cash Flow 11.05
Particulars MAR 2021 (Values in Cr)
Net Income -0.52
Cash from Operations -0.91
Cash from Investing -2.10
Cash from Financing 2.18
Net change in Cash -0.83
Free Cash Flow 0.03
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 14.41 1.68 267.30 23.12 40.00
BLISS GVS PHARMA LTD. 396.35 32.07 3.51 4192.95 118.35 399.00
CIPLA LTD 1418.20 28.08 3.32 114562.27 1165.55 1672.20
FERMENTA BIOTECH LIMITED 293.20 12.93 2.12 862.92 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 24.39 4.49 267.30 23.12 40.00
AMRUTAJAN HEALTH LTD 559.20 25.06 4.36 1616.68 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8655.30 104.02 27.08 21638.25 7630.00 10653.05
BLISS GVS PHARMA LTD. 396.35 42.62 3.62 4192.95 118.35 399.00

KERALA AYURVEDA LTD. shareholding pattern

Holding
64.19%
35.6%
0.16%
0.03%
20.35%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

KERALA AYURVEDA LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
203.40 -1.50 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 206.80
  • 26 Days 213.30
  • 10 Days 208.80
  • 50 Days 218.80
  • 12 Days 209.60
  • 100 Days 245.00
  • 20 Days 212.20
  • 200 Days 293.80
209.87 PIVOT
First Support 201.63 First Resistance 214.73 Second Support 196.77 Second Resistance 222.97 Third Support 188.53 Third Resistance 227.83
RSI 42.83 ADX 20.76 MACD -3.69 Williams % R -85.25 Commodity Channel Index (CCI) -72.54
Date 2026-05-27 Week 4279.00 Same Day 8016.00 Month 7402.00
1 Year 1.54 3 Year 0.99
Over 1 Month
-11.71% down
Over 1 Year
-50.88% down
Over 3 Months
-1.09% down
Over 3 Years
18.57% down
Over 6 Months
-47.20% down
Over 5 Years
31.21% down

KERALA AYURVEDA LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Kerala Ayurveda Ltd?

Answer Field

Kerala Ayurveda Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 203.40 as on May 27 2026 03:29 PM.

What is the Market Cap of Kerala Ayurveda Ltd Share?

Answer Field

The market cap of Kerala Ayurveda Ltd for NSE ₹ 0.00 & for BSE ₹ 264.30 as on May 27 2026 03:29 PM.

What is the 52 Week High and Low of Kerala Ayurveda Ltd?

Answer Field

The 52 Week High and Low of Kerala Ayurveda Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 625.00 and ₹ 150.00.

What is 1 year return for Kerala Ayurveda Ltd?

Answer Field

The 1 year returns on the stock has been -50.88%.

What is the P/E Ratio of Kerala Ayurveda Ltd Share?

Answer Field

As on May 27 2026 03:29 PM the price-to-earnings (PE) ratio for Kerala Ayurveda Ltd share is -17.94.

What is the PB ratio of Kerala Ayurveda Ltd Share?

Answer Field

As on May 27 2026 03:29 PM, the price-to-book (PB) ratio for Kerala Ayurveda Ltd share is 28.05.

How to Buy Kerala Ayurveda Ltd Share?

Answer Field

You can trade in Kerala Ayurveda Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kerala Ayurveda Ltd Share on Bajaj Broking App?

Answer Field

To buy Kerala Ayurveda Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kerala Ayurveda Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|